Startups Selected for the SGP Life Sciences Accelerator

Selected Startups

The following teams have been accepted into the SGP Life Sciences program:

• Mantiscope

• Fabs3DAI

• YaYo

• Cortex AI

• Body Tester

• Lekko

• Sino AI

• Cortivox AI

• Tomo24

• Nexgene AI

• ORTO

• SV Microbiology

• Shifa

• TAMES AI

• qMed AI

• Metaclinic

The selection process considered the founders’ expertise, scientific potential, stage of product development, ability to address real challenges in healthcare, and potential to expand into regional and international markets.

What to Expect from the Program

Over the next two months, the selected startups will work with global mentors, industry experts, and investors. Throughout the program, the teams will receive practical, tailored support to strengthen their businesses and prepare for international markets.

The program will focus on:

• regulatory strategy;

• clinical validation;

• go-to-market strategy;

• fundraising;

• international expansion.

As announced earlier, the program will also provide startups with opportunities to engage directly with global mentors and international investors, as well as explore potential financing and strategic partnership opportunities.

The program has started with a Kick-off on October 2, will be followed by a founder Team Meetup on October 8 and workshops till November 20th. On November 23–24, the startups will take part in an in-person Bootcamp in Uzbekistan, before presenting their projects at Demo Day on November 25 in Tashkent.

Advancing the Life Sciences Ecosystem in the Region

Through SGP Life Sciences, UzVC and DOMiNO Ventures continue to support promising founders working across Biotech, Healthtech, and Pharmatech in Central Asia.

The program aims to connect local and regional startups with international experts, venture capital funds, and investors, strengthen their investment readiness, and expand their opportunities to enter global markets.

Congratulations to all the selected teams! We look forward to supporting them throughout their acceleration journey.